Eplontersen
New Drug Approvals
DECEMBER 24, 2023
2] [3] [4] [5] It was approved for medical use in the United States in December 2023. [6] 1] Society and culture Names Eplontersen is the international nonproprietary name. [9] S2CID 250989659. ^ “Eplontersen: FDA-Approved Drugs” U.S. 1] It is a transthyretin-directed antisense oligonucleotide. [1]
Let's personalize your content